Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Julian Nomme"'
Autor:
Hélène Puja, Laurent Bianchetti, Johan Revol-Tissot, Nicolas Simon, Anastasiia Shatalova, Julian Nommé, Sarah Fritsch, Roland H. Stote, Gaëtan L. A. Mislin, Noëlle Potier, Annick Dejaegere, Coraline Rigouin
Publikováno v:
Microbial Cell Factories, Vol 23, Iss 1, Pp 1-16 (2024)
Abstract The engineering of non ribosomal peptide synthetases (NRPS) for new substrate specificity is a potent strategy to incorporate non-canonical amino acids into peptide sequences, thereby creating peptide diversity and broadening applications. T
Externí odkaz:
https://doaj.org/article/22b918acf0c04a738ddc527f2d7544cd
Autor:
Alain Milon, Audrey Tourdes, Cyprian D. Cukier, Virginie Gervais, Andreas Merdes, Valérie Guillet, Dounia El-Mazouni, Lionel Mourey, Julian Nomme
Publikováno v:
Protein Science. 26:2240-2248
MOZART1 (Mitotic-spindle organizing protein associated with a ring of γ-tubulin 1) is an 8.5 kDa protein linked to regulation of γ-tubulin ring complexes (γTuRCs), which are involved in nucleation of microtubules. Despite its small size, MOZART1 r
Autor:
Aleksandar Antanasijevic, Michael Caffrey, Arnon Lavie, Christina M. Van Itallie, James M. Anderson, Alan S. Fanning, Julian Nomme
Publikováno v:
Journal of Biological Chemistry. 290:16595-16606
The molecular seal between epithelial cells, called the tight junction (TJ), is built by several membrane proteins, with claudins playing the most prominent role. The scaffold proteins of the zonula occludens family are required for the correct local
Publikováno v:
Journal of Molecular Biology. 426:2471-2485
Our long-term goal is the design of a human l-asparaginase (hASNase3) variant, suitable for use in cancer therapy without the immunogenicity problems associated with the currently used bacterial enzymes. Asparaginases catalyze the hydrolysis of the a
Autor:
Arnon Lavie, Julian Nomme, Caius G. Radu, Steven T. Olson, Amanda L. Armijo, Jennifer M. Murphy, Natasha D. Sansone, Ying Su
Publikováno v:
Acta crystallographica. Section D, Biological crystallography, vol 70, iss Pt 1
Deoxycytidine kinase (dCK) is a key enzyme in the nucleoside salvage pathway that is also required for the activation of several anticancer and antiviral nucleoside analog prodrugs. Additionally, dCK has been implicated in immune disorders and has be
Publikováno v:
Chemistry and Biology
Summary Human asparaginase 3 (hASNase3), which belongs to the N-terminal nucleophile hydrolase superfamily, is synthesized as a single polypeptide that is devoid of asparaginase activity. Intramolecular autoproteolytic processing releases the amino g
Autor:
Pierre Weigel, Masayuki Takahashi, Susan F. Martinez, Fabrice Fleury, Axelle Renodon-Cornière, Damien Eveillard, Julian Nomme
Publikováno v:
Biochimie. 92:1832-1838
Human Rad51 (HsRad51), a key element of the homologous recombination repair pathway, is related to the resistance of cancer cells to chemo- and radio-therapies. This protein is thus a good target for the development of anti-cancer treatments. We have
Autor:
Masayuki Takahashi, Bengt Nordén, Axelle Renodon-Cornière, Kazuyasu Sakaguchi, Julian Nomme, V.H. Tran, Yuya Asanomi, Andrzej Stasiak, Alicja Z. Stasiak
Publikováno v:
Journal of Medicinal Chemistry, vol. 53, no. 15, pp. 5782-5791
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry
We have previously shown that a 28-amino acid peptide derived from the BRC4 motif of BRCA2 tumor suppressor inhibits selectively human RAD51 recombinase (HsRad51). With the aim of designing better inhibitors for cancer treatment, we combined an in si
Autor:
Susan F. Martinez, Ken Ichi Yamamoto, Fabrice Fleury, Yoshimasa Takizawa, Julian Nomme, Axelle Renodon-Cornière, Pierre Weigel, Masayuki Takahashi, Hitoshi Kurumizaka
Publikováno v:
Genes to Cells. 13:471-481
Human Rad51 is a key element of recombinational DNA repair and is related to the resistance of cancer cells to chemo- and radiotherapies. The protein is thus a potential target of anti-cancer treatment. The crystallographic analysis shows that the BR
Autor:
Tony Smith, Bernard D. Santarsiero, Arnon Lavie, Amanda L. Armijo, Johannes Czernin, Jue Wang, Michael E. Jung, Hien Anh Nguyen, Caius G. Radu, Thuc Le, Raymond M. Gipson, Julian Nomme, Zheng Li, Anastassia N. Alexandrova, Soumya Poddar
Publikováno v:
Journal of medicinal chemistry, vol 57, iss 22
Journal of Medicinal Chemistry
Nomme, J; Li, Z; Gipson, RM; Wang, J; Armijo, AL; Le, T; et al.(2014). Structure-guided development of deoxycytidine kinase inhibitors with nanomolar affinity and improved metabolic stability. Journal of Medicinal Chemistry, 57(22), 9480-9494. doi: 10.1021/jm501124j. UCLA: Retrieved from: http://www.escholarship.org/uc/item/9fv4j1bs
Journal of Medicinal Chemistry
Nomme, J; Li, Z; Gipson, RM; Wang, J; Armijo, AL; Le, T; et al.(2014). Structure-guided development of deoxycytidine kinase inhibitors with nanomolar affinity and improved metabolic stability. Journal of Medicinal Chemistry, 57(22), 9480-9494. doi: 10.1021/jm501124j. UCLA: Retrieved from: http://www.escholarship.org/uc/item/9fv4j1bs
© 2014 American Chemical Society. Recently, we have shown that small molecule dCK inhibitors in combination with pharmacological perturbations of de novo dNTP biosynthetic pathways could eliminate acute lymphoblastic leukemia cells in animal models.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ed3f11060d74e247782e3622cb5968a
https://escholarship.org/uc/item/9fv4j1bs
https://escholarship.org/uc/item/9fv4j1bs